A scholarship program enabled by the Clause family’s generous donations to the Institute has been awarded to Jiaqian (Emily) Wu, a graduate student in the lab of Nicholas Cosford, Ph.D., co-director and professor of the Cancer Therapeutics Program.

Zeroing in on hepatic myofibroblasts while simultaneously addressing the underlying cause(s) of liver damage may be the key to reversing liver fibrosis. A new review by David Brenner, M.D., describes the emerging therapeutic approach.

An accomplished group of early-career researchers including postdoctoral scholars, graduate students and staff scientists showcased their work at Sanford Burnham Prebys’ 22nd Annual Trainee Research Symposium on Thursday, September 21st.

Three talented early-career researchers were presented with prestigious Fishman Fund Awards at the 22nd annual ceremony on September 20.

Lukas Chavez, Ph.D., has received $3.2 million from the National Institutes of Health to study how unique DNA circles found in cancer cells drive deadly pediatric brain tumors.

Svasti Haricharan, Ph.D., was the first guest on Stop & Talk—a new podcast offered by The Conrad Prebys Foundation. In the broadcast, Svasti shares how she came to be a research leader in therapy-resistant breast cancer and how race affects clinical outcomes.

Cosimo Commisso, Ph.D., has received a grant from the Department of Defense for $1 million to advance the research of a small molecule that kills pancreatic cancer cells by disrupting their pH equilibrium.

With the help of a new grant from the National Institutes of Health for more than $2.6 million, Assistant Professor Timothy Huang, Ph.D., will continue his research on the role of the brain’s immune cells on the risk of developing Alzheimer’s disease.

A collaborative study led by researchers at Sanford Burnham Prebys is paving the way to identifying gene networks that cause atrial fibrillation (AFib), the most common age-related cardiac arrhythmia.

Sanford Burnham Prebys’ Cancer Center has received a rare and prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing and rewarding its earlier accomplishments as well as current research plans. The award extends the center’s current 5-year Cancer Center Support Grant (CCSG) for an additional two years.

New and rapidly developing technologies, such as cryo-electron (cryo-EM) and artificial intelligence, are providing the tools to revolutionize biomedical research, but you need scientists who know how to use them.

This month, researchers in Sweden published a study that compared the efficacy of artificial intelligence-supported mammogram screening versus the standard double reading by radiologists. Ze’ev Ronai, Ph.D. was interviewed.